Order only for patients with an established diagnosis of a BCR-ABL1-positive leukemia. Use to determine if a variant is present that would interfere with response to TKI therapy in Philadelphia chromosome positive (Ph+) lymphoblastic leukemia or chronic myelogenous leukemia (CML). Detects all common mutations, including T315I. For initial BCR-ABL1 testing, refer to Diagnostic Qualitative BCR-ABL1 Assay with Reflex to p190 or p210 Quantitative Assays (3005839).
EPIC Code
LAB8852
Note: BM Core biopsy sample in RPMI media is an acceptable sample type.
Interpretive Data
Refer to report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
CPT Codes
81170
Collection
EPIC Code
LAB8852
Note: BM Core biopsy sample in RPMI media is an acceptable sample type.
Performing Lab
ARUP Laboratories (test code: 2008420)
Collect
Lavender (EDTA) or bone marrow (EDTA).
Specimen Preparation
Transport 5 mL whole blood or 3 mL bone marrow. (Min: 1 mL)
Unacceptable Conditions
Serum or plasma. Specimens collected in anticoagulants other than EDTA. Frozen Specimens. Clotted or severely hemolyzed specimens.
Order only for patients with an established diagnosis of a BCR-ABL1-positive leukemia. Use to determine if a variant is present that would interfere with response to TKI therapy in Philadelphia chromosome positive (Ph+) lymphoblastic leukemia or chronic myelogenous leukemia (CML). Detects all common mutations, including T315I. For initial BCR-ABL1 testing, refer to Diagnostic Qualitative BCR-ABL1 Assay with Reflex to p190 or p210 Quantitative Assays (3005839).
EPIC Code
LAB8852
Note: BM Core biopsy sample in RPMI media is an acceptable sample type.
Result Interpretation
Interpretive Data
Refer to report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratories.